美年健康数据资源增长71.3%，预计数据可反哺保险产品研发

Core Insights - The core viewpoint of the article highlights the significant growth in data resources reported by Meinian Health in its 2024 annual report, with a notable increase of 71.3% compared to the first quarter's disclosure [1] Group 1: Data Resources - Meinian Health disclosed data resources amounting to 9.352 million yuan in 2024, up from 5.46 million yuan in the first quarter [1] - The company has accumulated over 100 million imaging data points and more than 200 million structured health data points, establishing the largest personal health examination data center in China [1] - The accounting treatment of data resources in 2024 shows a transitional characteristic, with 882,000 yuan transferred to "intangible assets" and 53,000 yuan remaining in "development expenses" [1] Group 2: Research and Development - Key R&D projects include the Bianque SAAS health examination management platform and the Xingyu business development platform, with the latter expected to provide data value for insurance product development [1] - The company has seen a structural adjustment in R&D investment and personnel, with R&D expenditures decreasing from 1.38 million yuan in 2021 to 980,000 yuan in 2023, before rising to 1.1 million yuan in 2024, a 12.2% increase year-on-year [9] - Despite the increase in R&D investment in 2024, the number of R&D personnel decreased from 375 in 2023 to 270 in 2024, indicating a potential shift in strategy [9]